Medpace
MEDP
604.25
+1.35
+0.22%
Medpace
US · MEDP
#1015 by market cap
Listed 2016
604.25
+1.35
+0.22%
Live - 5344 symbols - heartbeat 485s ago
· 2026-10-08 03:14
After-hours
604.25
0.00%
Overnight
604.25
0.00%
- Market cap
- 16.87B
- P/E (TTM)i
- 35.50
- P/Bi
- 38.87
- EPSi
- 15.28
- Div yieldi
- 0.00%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on MEDP?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Hold
Avg price target
629.86 +4.2%
Price target rangecurrent 604.25
Low535.00
Avg629.86
High692.00
Buy 22%
Hold 78%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | UBS | -- | HOLD | 673.00 |
| 2026-09-17 | Truist Financial | -- | HOLD | -- |
| 2026-07-28 | Mizuho Securities | -- | BUY | 665.00 |
| 2026-07-28 | Truist Financial | -- | HOLD | 609.00 |
| 2026-07-24 | Mizuho Securities | -- | BUY | 665.00 |
| 2026-07-24 | Truist Financial | -- | HOLD | 609.00 |
| 2026-07-24 | Baird | -- | HOLD | 624.00 |
| 2026-07-23 | William Blair | -- | HOLD | -- |
| 2026-07-23 | Truist Financial | -- | HOLD | -- |
| 2026-07-23 | Deutsche Bank | -- | HOLD | 535.00 |
| 2026-07-23 | BMO Capital | -- | HOLD | 600.00 |
| 2026-07-23 | Leerink Partners | -- | HOLD | 620.00 |
| 2026-07-23 | RBC Capital | -- | BUY | 692.00 |
| 2026-07-22 | William Blair | -- | HOLD | -- |
| 2026-07-13 | Mizuho Securities | -- | BUY | 586.00 |
| 2026-07-08 | Baird | -- | HOLD | 547.00 |
| 2026-06-15 | Jefferies | -- | BUY | 490.00 |
| 2026-04-24 | Mizuho Securities | -- | BUY | 495.00 |
| 2026-04-24 | Truist Financial | -- | HOLD | 462.00 |
| 2026-04-24 | Baird | -- | BUY | 477.00 |
| 2026-04-24 | BMO Capital | -- | HOLD | 400.00 |
| 2026-04-24 | Barclays | -- | HOLD | 450.00 |
| 2026-04-23 | Truist Financial | -- | HOLD | -- |
| 2026-04-15 | RBC Capital | -- | BUY | 522.00 |
| 2026-03-10 | RBC Capital | -- | BUY | 522.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Hold
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
2 1
■ Upgrades■ Downgrades
- 2 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Baird moved from Buy to Hold on 2026-07-08.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-08 | Baird | BUY → HOLD | 547.00 |
| 2026-03-06 | Barclays | SELL → HOLD | 500.00 |
| 2026-02-10 | Baird | HOLD → BUY | 564.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-22 | After close | ±15.30% | +14.71% (in line) |
| 2026/Q1 | 2026-04-22 | After close | ±14.69% | -22.63% (beat) |
| 2025/Q4 | 2026-02-09 | After close | ±11.56% | -15.90% (beat) |
| 2025/Q3 | 2025-10-22 | After close | ±13.98% | +9.12% (in line) |
| 2025/Q2 | 2025-07-21 | After close | ±13.70% | +54.67% (beat) |
| 2025/Q1 | 2025-04-21 | After close | ±15.75% | -2.32% (in line) |
| 2024/Q4 | 2025-02-10 | After close | ±11.60% | -7.52% (in line) |
| 2024/Q3 | 2024-10-21 | After close | ±15.79% | -7.47% (in line) |
| 2024/Q2 | 2024-07-22 | After close | ±13.00% | -18.27% (beat) |
| 2024/Q1 | 2024-04-22 | After close | ±13.36% | +8.21% (in line) |
| 2023/Q4 | 2024-02-12 | After close | ±12.20% | +12.30% (beat) |
| 2023/Q2 | 2023-07-24 | After close | ±10.85% | +3.91% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 03:14:43 · For reference only, not investment advice and not tailored to your situation.